| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | MDV 3100 | FAERS: 2 | US FAERS | |
| 2 | ponatinib | FAERS: 2 | US FAERS | |
| 3 | rofecoxib | FAERS: 2 | US FAERS | |
| 4 | Bosentan | FAERS: 1 | US FAERS | |
| 5 | Clozapine | FAERS: 1 | US FAERS | |
| 6 | Cyclosporine | FAERS: 1 | US FAERS | |
| 7 | Deferasirox | FAERS: 1 | US FAERS | |
| 8 | Digoxin | FAERS: 1 | US FAERS | |
| 9 | Everolimus | FAERS: 1 | US FAERS | |
| 10 | Sertraline | FAERS: 1 | US FAERS | |
| 11 | Sildenafil Citrate | FAERS: 1 | US FAERS | |
| 12 | Telmisartan | FAERS: 1 | US FAERS | |
| 13 | ambrisentan | FAERS: 1 | US FAERS | |
| 14 | Calcium Citrate | OFFSIDES | ||
| 15 | Mitoxantrone | OFFSIDES | ||
| 16 | Panipenem-betamipron | OFFSIDES | ||
| 17 | Salmeterol Xinafoate | OFFSIDES | ||
| 18 | arbekacin | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.